These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27006102)

  • 1. Quality of red cells after combination of prion reduction and treatment with the intercept system for pathogen inactivation.
    Wiltshire M; Meli A; Schott MA; Erickson A; Mufti N; Thomas S; Cardigan R
    Transfus Med; 2016 Jun; 26(3):208-14. PubMed ID: 27006102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion.
    Hornsey VS; Casey C; McColl K; Young H; Drummond O; McMillan L; Morrison A; Prowse CV
    Vox Sang; 2011 Jul; 101(1):28-34. PubMed ID: 21175669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of red-cell concentrates in SAG-M filtered through the MacoPharma P-CAPT prion-reduction filter.
    Murphy CV; Eakins E; Fagan J; Croxon H; Murphy WG
    Transfus Med; 2009 Jun; 19(3):109-16. PubMed ID: 19566667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipaemic plasma induces haemolysis in resuspended red cell concentrate.
    Bashir S; Wiltshire M; Cardigan R; Thomas S
    Vox Sang; 2013 Apr; 104(3):218-24. PubMed ID: 23106259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood.
    Schubert P; Culibrk B; Chen D; Serrano K; Levin E; Chen Z; Zoescher P; Goodrich RP; Yoshida T; Devine DV
    Transfusion; 2019 Oct; 59(10):3197-3204. PubMed ID: 31408208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogen inactivation of whole blood and red cell components: an overview of concept, design, developments, criteria of acceptability and storage lesion.
    Seghatchian J; Putter JS
    Transfus Apher Sci; 2013 Oct; 49(2):357-63. PubMed ID: 23962395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated short-term warming of red blood cell concentrates has minimal effect on their quality.
    Thomas S; Hancock V; Cardigan R
    Vox Sang; 2012 Aug; 103(2):113-21. PubMed ID: 22404883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion of prion-filtered red cells does not increase the rate of alloimmunization or transfusion reactions in patients: results of the UK trial of prion-filtered versus standard red cells in surgical patients (PRISM A).
    Elebute MO; Choo L; Mora A; MacRury C; Llewelyn C; Purohit S; Hicks V; Casey C; Malfroy M; Deary A; Reed T; Meredith S; Manson L; Williamson LM
    Br J Haematol; 2013 Mar; 160(5):701-8. PubMed ID: 23294293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double red cell concentrates -in vitro quality after delayed refrigeration.
    Thomas S; Bekoe Y; Uddin S; Beard M; Cardigan R
    Transfus Med; 2010 Oct; 20(5):315-21. PubMed ID: 20456686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Component pathogen inactivation: a critical review.
    Prowse CV
    Vox Sang; 2013 Apr; 104(3):183-99. PubMed ID: 23134556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation.
    Trannoy LL; Terpstra FG; de Korte D; Lagerberg JW; Verhoeven AJ; Brand A; van Engelenburg FA
    Vox Sang; 2006 Aug; 91(2):111-8. PubMed ID: 16907871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of P-Capt prion-filtered red blood cell products demonstrate acceptable in vivo viability and no evidence of neoantigen formation.
    Cancelas JA; Rugg N; Pratt PG; Worsham DN; Pehta JC; Banks K; Davenport RD; Judd WJ
    Transfusion; 2011 Oct; 51(10):2228-36. PubMed ID: 21492178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of X-irradiation on the quality of red cell concentrates.
    Bashir S; Naik F; Cardigan R; Thomas S
    Vox Sang; 2011 Oct; 101(3):200-7. PubMed ID: 21492185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
    Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
    Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
    Winter KM; Johnson L; Kwok M; Vidovic D; Hyland RA; Mufti N; Erickson A; Marks DC
    Transfusion; 2014 Jul; 54(7):1798-807. PubMed ID: 24617658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of buffy coat removed red cell concentrates--a Croatian experience.
    Vuk T; Očić T; Patko MS; Jukić I
    Transfus Med; 2014 Dec; 24(6):385-91. PubMed ID: 25469715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory assessment of the quality of adult and neonatal red cell concentrates manufactured from whole blood, exchange transfusion or intrauterine transfusion red cell units.
    Meli A; New H; McAndrew M; Wiltshire M; Cardigan R
    Vox Sang; 2018 May; ():. PubMed ID: 29774554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell concentrate storage and transport temperature.
    Hancock V; Cardigan R; Thomas S
    Transfus Med; 2011 Oct; 21(5):325-9. PubMed ID: 21707796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial pseudohyperkalemia induces significantly higher levels of extracellular potassium in early storage of red cell concentrates without affecting other standard measures of quality: A case control and allele frequency study.
    Meli A; McAndrew M; Frary A; Rehnstrom K; Stevens-Hernandez CJ; Flatt JF; Griffiths A; Stefanucci L; Astle W; Anand R; New HV; Bruce LJ; Cardigan R
    Transfusion; 2021 Aug; 61(8):2439-2449. PubMed ID: 33960432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion reduction of red blood cells: impact on component quality.
    Wiltshire M; Thomas S; Scott J; Hicks V; Haines M; Cookson P; Garwood M; Cardigan R
    Transfusion; 2010 May; 50(5):970-9. PubMed ID: 19951322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.